デフォルト表紙
市場調査レポート
商品コード
1609835

日本のウィメンズヘルス市場レポート:年齢層タイプ、用途、流通チャネル、地域別、2024年~2032年

Japan Women's Health Market Report by Age Group Type, Application, Distribution Channel, and Region 2024-2032


出版日
発行
IMARC
ページ情報
英文 119 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.81円
日本のウィメンズヘルス市場レポート:年齢層タイプ、用途、流通チャネル、地域別、2024年~2032年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 119 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のウィメンズヘルス市場の市場規模は2023年に24億1,900万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに32億7,800万米ドルに達し、2024年から2032年の間に3.4%の成長率(CAGR)を示すと予測しています。ロボット支援手術、低侵襲手術、遠隔医療など、医療技術の進歩が進み、女性の健康状態の診断や治療の選択肢が増えたことが、主に市場を牽引しています。

本レポートで扱う主な質問

  • 日本のウィメンズヘルス市場はこれまでどのように推移し、今後どのように推移していくのか?
  • COVID-19が日本のウィメンズヘルス市場に与えた影響は?
  • 日本のウィメンズヘルス市場の年齢層別の内訳は?
  • 日本のウィメンズヘルス市場の用途別の内訳は?
  • 日本のウィメンズヘルス市場の流通チャネル別の内訳は?
  • 日本のウィメンズヘルス市場のバリューチェーンにはどのような段階がありますか?
  • 日本のウィメンズヘルスに関する主な促進要因と課題は何ですか?
  • 日本のウィメンズヘルス市場の構造と主要プレーヤーは?
  • 日本のウィメンズヘルス市場における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のウィメンズヘルス市場:イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のウィメンズヘルス市場情勢

  • 過去および現在の市場動向(2018~2023年)
  • 市場予測(2024~2032年)

第6章 日本のウィメンズヘルス市場:年齢層タイプ別の内訳

  • 50歳以上
  • その他

第7章 日本のウィメンズヘルス市場:用途別の内訳

  • 避妊薬
  • 骨粗鬆症
  • 閉経
  • 不妊
  • その他

第8章 日本のウィメンズヘルス市場:流通チャネル別の内訳

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 日本のウィメンズヘルス市場:競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第10章 主要企業のプロファイル

第11章 日本のウィメンズヘルス市場:業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第12章 付録

目次
Product Code: SR112024A18343

Japan women's health market size reached US$ 2,419.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,278.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.4% during 2024-2032. The increasing advances in medical technology, such as robotic-assisted surgery, minimally invasive procedures, and telemedicine, which have improved the diagnosis and treatment options available for women's health conditions, are primarily driving the market.

Women's health refers to the unique physical, mental, and emotional well-being of women across their lifespan. It encompasses a wide range of issues, including reproductive health, sexual health, and overall physical fitness. Key aspects of women's health include menstrual and menopausal health, pregnancy and childbirth, contraception, breast health, and gynecological care. Regular check-ups, screenings, and access to healthcare are essential to maintaining women's health. This includes Pap smears, mammograms, and discussions about family planning. Mental health is also crucial, as women are more susceptible to conditions like depression and anxiety. A healthy lifestyle, including a balanced diet, regular exercise, and stress management, plays a significant role in women's health. Additionally, promoting gender equality and addressing societal factors that affect women's health, such as discrimination and unequal access to healthcare, are essential steps toward ensuring that women can lead healthy and fulfilling lives. Women's health is a multifaceted and critical aspect of public health, deserving attention and support.

Japan Women's Health Market Trends:

The women's health market in Japan is multifaceted and interconnected, driven by various factors that collectively shape the landscape of healthcare for women. Firstly, advances in medical research and technology have significantly propelled the women's health market forward. Breakthroughs in diagnostic tools, such as mammography and genetic testing, have enhanced the early detection of diseases like breast cancer and hereditary conditions, improving overall health outcomes. Secondly, the growing awareness of women's unique healthcare needs has played a pivotal role. Women are increasingly informed about the importance of preventive care, leading to higher demand for gynecological services, contraceptives, and maternity care. Furthermore, societal shifts, including delayed childbirth and an aging female population, have contributed to the expansion of this market. These shifts require tailored healthcare solutions, driving innovation and investment in women's health services. Moreover, various regulatory changes and government initiatives improve access to healthcare through several policies, thereby enhancing the affordability and availability of women's health services. This, in turn, is expected to drive the women's health market in Japan during the forecast period.

Japan Women's Health Market Segmentation:

Age Group Type Insights:

50 Years and Above

  • Postmenopausal Osteoporosis
  • Endometriosis and Uterine Fibroids
  • Menopause
  • Others

Application Insights:

  • Contraceptives
  • Osteoporosis
  • Menopause
  • Infertility
  • Others

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan women's health market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan women's health market?
  • What is the breakup of the Japan women's health market on the basis of age group type?
  • What is the breakup of the Japan women's health market on the basis of application?
  • What is the breakup of the Japan women's health market on the basis of distribution channel?
  • What are the various stages in the value chain of the Japan women's health market?
  • What are the key driving factors and challenges in the Japan women's health?
  • What is the structure of the Japan women's health market and who are the key players?
  • What is the degree of competition in the Japan women's health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Women's Health Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Women's Health Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Women's Health Market - Breakup by Age Group Type

  • 6.1 50 Years and Above
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Postmenopausal Osteoporosis
      • 6.1.3.2 Endometriosis and Uterine Fibroids
      • 6.1.3.3 Menopause
    • 6.1.4 Market Forecast (2024-2032)
  • 6.2 Others
    • 6.2.1 Historical and Current Market Trends (2018-2023)
    • 6.2.2 Market Forecast (2024-2032)

7 Japan Women's Health Market - Breakup by Application

  • 7.1 Contraceptives
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Osteoporosis
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Menopause
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)
  • 7.4 Infertility
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2018-2023)
    • 7.4.3 Market Forecast (2024-2032)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2018-2023)
    • 7.5.2 Market Forecast (2024-2032)

8 Japan Women's Health Market - Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Retail Pharmacies
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Online Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)

9 Japan Women's Health Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Women's Health Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix